170 related articles for article (PubMed ID: 18816111)
1. Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships.
Brandt GE; Schmidt MD; Prisinzano TE; Blagg BS
J Med Chem; 2008 Oct; 51(20):6495-502. PubMed ID: 18816111
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 inhibitor gedunin causes apoptosis in A549 lung cancer cells by disrupting Hsp90:Beclin-1:Bcl-2 interaction and downregulating autophagy.
Hasan A; Haque E; Hameed R; Maier PN; Irfan S; Kamil M; Nazir A; Mir SS
Life Sci; 2020 Sep; 256():118000. PubMed ID: 32585246
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Anticancer Effect of Gedunin on Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells.
Tharmarajah L; Samarakoon SR; Ediriweera MK; Piyathilaka P; Tennekoon KH; Senathilake KS; Rajagopalan U; Galhena PB; Thabrew I
Biomed Res Int; 2017; 2017():2413197. PubMed ID: 28680880
[TBL] [Abstract][Full Text] [Related]
4. Bioactive limonoids from the leaves of Azaridachta indica (Neem).
Gualtieri MJ; Malafronte N; Vassallo A; Braca A; Cotugno R; Vasaturo M; De Tommasi N; Dal Piaz F
J Nat Prod; 2014 Mar; 77(3):596-602. PubMed ID: 24499352
[TBL] [Abstract][Full Text] [Related]
5. Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.
Patwardhan CA; Fauq A; Peterson LB; Miller C; Blagg BS; Chadli A
J Biol Chem; 2013 Mar; 288(10):7313-25. PubMed ID: 23355466
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitors identified from a library of novobiocin analogues.
Yu XM; Shen G; Neckers L; Blake H; Holzbeierlein J; Cronk B; Blagg BS
J Am Chem Soc; 2005 Sep; 127(37):12778-9. PubMed ID: 16159253
[TBL] [Abstract][Full Text] [Related]
7. Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages.
Borges PV; Moret KH; Maya-Monteiro CM; Souza-Silva F; Alves CR; Batista PR; Caffarena ER; Pacheco P; Henriques Md; Penido C
Mol Pharmacol; 2015 Nov; 88(5):949-61. PubMed ID: 26330549
[TBL] [Abstract][Full Text] [Related]
8. Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation.
Blagg BS; Kerr TD
Med Res Rev; 2006 May; 26(3):310-38. PubMed ID: 16385472
[TBL] [Abstract][Full Text] [Related]
9. Gedunin and Azadiradione: Human Pancreatic Alpha-Amylase Inhibiting Limonoids from Neem (Azadirachta indica) as Anti-Diabetic Agents.
Ponnusamy S; Haldar S; Mulani F; Zinjarde S; Thulasiram H; RaviKumar A
PLoS One; 2015; 10(10):e0140113. PubMed ID: 26469405
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors.
Audisio D; Methy-Gonnot D; Radanyi C; Renoir JM; Denis S; Sauvage F; Vergnaud-Gauduchon J; Brion JD; Messaoudi S; Alami M
Eur J Med Chem; 2014 Aug; 83():498-507. PubMed ID: 24992077
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of natural products from the Indian neem tree Azadirachta indica.
Veitch GE; Pinto A; Boyer A; Beckmann E; Anderson JC; Ley SV
Org Lett; 2008 Feb; 10(4):569-72. PubMed ID: 18193879
[TBL] [Abstract][Full Text] [Related]
12. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
[TBL] [Abstract][Full Text] [Related]
13. Limonoids from neem (Azadirachta indica A. Juss.) are potential anticancer drug candidates.
Nagini S; Palrasu M; Bishayee A
Med Res Rev; 2024 Mar; 44(2):457-496. PubMed ID: 37589457
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.
Hieronymus H; Lamb J; Ross KN; Peng XP; Clement C; Rodina A; Nieto M; Du J; Stegmaier K; Raj SM; Maloney KN; Clardy J; Hahn WC; Chiosis G; Golub TR
Cancer Cell; 2006 Oct; 10(4):321-30. PubMed ID: 17010675
[TBL] [Abstract][Full Text] [Related]
15. Radester, a novel inhibitor of the Hsp90 protein folding machinery.
Shen G; Blagg BS
Org Lett; 2005 May; 7(11):2157-60. PubMed ID: 15901158
[TBL] [Abstract][Full Text] [Related]
16. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
Kim T; Keum G; Pae AN
Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of neolamellarin a derivatives targeting heat shock protein 90.
Jiang L; Yin R; Wang X; Dai J; Li J; Jiang T; Yu R
Eur J Med Chem; 2017 Jul; 135():24-33. PubMed ID: 28426997
[TBL] [Abstract][Full Text] [Related]
18. Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
Musso L; Dallavalle S; Merlini L; Bava A; Nasini G; Penco S; Giannini G; Giommarelli C; De Cesare A; Zuco V; Vesci L; Pisano C; Castorina M; Milazzo F; Cervoni ML; Dal Piaz F; De Tommasi N; Zunino F
Bioorg Med Chem; 2010 Aug; 18(16):6031-43. PubMed ID: 20655237
[TBL] [Abstract][Full Text] [Related]
19. Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.
Burlison JA; Avila C; Vielhauer G; Lubbers DJ; Holzbeierlein J; Blagg BS
J Org Chem; 2008 Mar; 73(6):2130-7. PubMed ID: 18293999
[TBL] [Abstract][Full Text] [Related]
20. Novobiocin: redesigning a DNA gyrase inhibitor for selective inhibition of hsp90.
Burlison JA; Neckers L; Smith AB; Maxwell A; Blagg BS
J Am Chem Soc; 2006 Dec; 128(48):15529-36. PubMed ID: 17132020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
